APA Citation

Mahmud, F., Deng, S., Chen, H., Miller, D. D., & Li, W. (2020). Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer. Cancer Lett.

Citação norma Chicago

Mahmud, Foyez, Shanshan Deng, Hao Chen, Duane D. Miller, and Wei Li. "Orally Available Tubulin Inhibitor VERU-111 Enhances Antitumor Efficacy in Paclitaxel-resistant Lung Cancer." Cancer Lett 2020.

MLA Citation

Mahmud, Foyez, et al. "Orally Available Tubulin Inhibitor VERU-111 Enhances Antitumor Efficacy in Paclitaxel-resistant Lung Cancer." Cancer Lett 2020.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.